Dynavax Technologies (DVAX) Stock Price, Quote & News

Company Profile

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally. The company offers HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in adults aged 18 years and older; and CpG 1018, the adjuvant used in HEPLISAV-B. It also develops rF1V, a plague vaccine candidate in Phase 2 clinical trial; and Z-1018, an investigational vaccin...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 510 848 5100

Fax: 510 848 1327

Website: www.dynavax.com

Address:

2100 Powell Street, Suite 720, EmeryVille, United States

KWalzz Jun. 26 at 8:05 PM

$DVAX 7 cents up, WOW, is another mice trial or a trial completing in late 2028 around the corner? isnt this cool how strong this ticker was today? LMAO (what else)

0 · Reply

KWalzz Jun. 26 at 7:14 AM

$DVAX from YMB and so true ... "all these mice studies" LMAO .... .

0 · Reply

KWalzz Jun. 25 at 8:44 PM

$DVAX don't think anyone is interested, but here the update on short interest (source: nasdaq) ... no change here.

0 · Reply

KWalzz Jun. 25 at 2:14 PM

$DVAX just another month and we will see how Heplisav sales were developing (or not). the first milestone after the proxy vote for our boys, Scotty and Ryan!

1 · Reply

KWalzz Jun. 25 at 2:00 PM

$DVAX do not invest here until real news is offered by management (LOL). repeat: do not invest here until REAL NEWS is offered by management (LOL again).

0 · Reply

AccuRoger Jun. 25 at 1:57 PM

$DVAX This is an interesting new Human Trial in China. It compares CpG 1018 against other adjuvants for a Zoster vaccine (Shingles). May the least painful option win. https://clinicaltrials.gov/study/NCT06851832?intr=CpG1018&aggFilters=status:not%20rec&sort=StudyFirstPostDate&rank=1

0 · Reply

KWalzz Jun. 24 at 7:21 PM

$DVAX where are R & S? in there?

0 · Reply

KWalzz Jun. 24 at 3:01 PM

$BBIO so I'm up 40% now from April, 7th when I bought in as a hedge to the super-loser $DVAX (down 20%) ... see, Myers and Spencer what a real gem in bio world delivers to its shareholders when good people steer the ship.

0 · Reply

KWalzz Jun. 24 at 1:46 PM

$DVAX Scott Myers and Ryan Spencer work so hard, unbelievable how much of shareholder value they created in the last days and weeks. Isnt now the time already to celebrate this with a new round of Form 4s, no? not drunk enough yet?

0 · Reply

HeadlessHorsemen Jun. 23 at 8:15 PM

$DVAX Well, I feel so much better now. DVAX is in its cozy spot at $9+. Thanks GS and Scott Myers! You guys really know how to run a company!!!!

0 · Reply

Dynavax elects all four of its nominees after Deep Track proxy fight

Jun 11, 2025, 11:01 AM EDT - 15 days ago

Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting

Jun 9, 2025, 8:30 AM EDT - 17 days ago

Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom

Jun 9, 2025, 7:30 AM EDT - 17 days ago

Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting

Jun 4, 2025, 4:59 PM EDT - 22 days ago

Dynavax Comments on Glass Lewis Recommendation

Jun 4, 2025, 9:27 AM EDT - 22 days ago

Glass Lewis Recommends Shareholders Support Deep Track's Case for Board Change at Dynavax Technologies

May 28, 2025, 4:10 PM EDT - 4 weeks ago

Dynavax to Present at William Blair's 45th Annual Growth Stock Conference

May 23, 2025, 6:12 PM EDT - 4 weeks ago

Deep Track Capital Comments on ISS Recommendation

May 23, 2025, 1:54 PM EDT - 4 weeks ago

ISS backs Dynavax directors in board fight with Deep Track Capital

May 23, 2025, 1:44 PM EDT - 4 weeks ago

Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote "FOR" All Four of Dynavax's Highly Qualified Director Nominees

May 21, 2025, 11:48 PM EDT - 5 weeks ago

Dynavax Technologies: Hepatitis-B Vaccine Specialist Looking Good

May 15, 2025, 4:00 PM EDT - 6 weeks ago

Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting

May 12, 2025, 7:30 AM EDT - 6 weeks ago

Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value

May 7, 2025, 4:45 PM EDT - 7 weeks ago

Dynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum

May 6, 2025, 7:34 PM EDT - 7 weeks ago

Dynavax Technologies Corporation (DVAX) Q1 2025 Earnings Call Transcript

May 6, 2025, 4:01 PM EDT - 7 weeks ago

Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs

May 6, 2025, 8:00 AM EDT - 7 weeks ago

Deep Track Capital Releases Investor Presentation on Dynavax Technologies

May 1, 2025, 8:00 AM EDT - 2 months ago

Dynavax Announces Nationwide Harris Poll Survey Results Finding Americans Underestimate the Serious Consequences of Hepatitis B and Vaccine Protection Benefits

Apr 29, 2025, 7:30 AM EDT - 2 months ago

Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy

Apr 22, 2025, 4:00 PM EDT - 2 months ago

Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025

Apr 21, 2025, 4:05 PM EDT - 2 months ago

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Apr 17, 2025, 7:15 AM EDT - 2 months ago

Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders

Apr 16, 2025, 8:00 AM EDT - 2 months ago

Deep Track Capital Comments on Dynavax Technologies' Rejection of Most Recent Settlement Offer

Apr 3, 2025, 5:40 PM EDT - 3 months ago

Dynavax Files Preliminary Proxy Statement

Mar 10, 2025, 8:00 AM EDT - 3 months ago

Deep Track Capital Sends Letter to Dynavax Technologies' Board of Directors

Mar 6, 2025, 6:00 AM EST - 4 months ago

Dynavax Announces Convertible Debt Refinancing and Common Stock Share Repurchase

Mar 3, 2025, 5:58 PM EST - 4 months ago

Dynavax Technologies: A Post-Earnings Assessment With Growing Market Share

Feb 25, 2025, 4:10 PM EST - 4 months ago

Dynavax to Participate in Upcoming Investor Conferences

Feb 20, 2025, 6:38 PM EST - 4 months ago

Dynavax Technologies Corporation (DVAX) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 4:01 PM EST - 4 months ago

Dynavax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Financial Guidance

Feb 19, 2025, 4:52 PM EST - 4 months ago

Dynavax Responds to Deep Track and Highlights Long-Term Value Creation Strategy

Feb 19, 2025, 9:00 AM EST - 4 months ago

Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies' Board of Directors at 2025 Annual Meeting

Feb 19, 2025, 8:04 AM EST - 4 months ago

Exclusive: Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors

Feb 11, 2025, 3:11 PM EST - 4 months ago

Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty

Feb 6, 2025, 5:42 PM EST - 5 months ago

Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025

Jan 27, 2025, 6:00 AM EST - 5 months ago

Dynavax Advances Board Refreshment Program

Jan 13, 2025, 9:00 AM EST - 5 months ago

Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Highlights

Nov 26, 2024, 4:05 PM EST - 7 months ago

Dynavax to Present at the 7th Annual Evercore HealthCONx Conference

Nov 13, 2024, 6:36 PM EST - 8 months ago

Dynavax Technologies: What The Stock Buyback Means. What It Doesn't

Nov 11, 2024, 8:00 AM EST - 8 months ago

Dynavax Announces $100 Million Accelerated Share Repurchase Program

Nov 7, 2024, 7:46 PM EST - 8 months ago

Dynavax Technologies Corporation (DVAX) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:02 PM EST - 8 months ago

Dynavax Reports Third Quarter 2024 Financial Results and Provides Business Updates

Nov 7, 2024, 4:01 PM EST - 8 months ago

Dynavax Announces $200 Million Share Repurchase Program

Nov 6, 2024, 1:10 PM EST - 8 months ago

Glancy Prongay & Murray LLP Announces Investigation of Dynavax Technologies Corporation (DVAX)

Oct 29, 2024, 8:30 AM EDT - 8 months ago

Dynavax Adopts Limited-Duration Stockholder Rights Plan

Oct 24, 2024, 4:10 PM EDT - 8 months ago

Dynavax to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024

Sep 25, 2024, 12:46 PM EDT - 9 months ago

3 'Repeatable' Biotech Trades

FOLD GSK NTLA XBI

Aug 23, 2024, 4:32 AM EDT - 10 months ago

Dynavax Technologies: A Two Trick Pony Operating With A Single Trick

Aug 6, 2024, 8:54 PM EDT - 11 months ago

Dynavax Technologies Corporation (DVAX) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 4:01 PM EDT - 11 months ago

Dynavax Reports Second Quarter 2024 Financial Results and Provides Business Updates

KWalzz Jun. 26 at 8:05 PM

$DVAX 7 cents up, WOW, is another mice trial or a trial completing in late 2028 around the corner? isnt this cool how strong this ticker was today? LMAO (what else)

0 · Reply

KWalzz Jun. 26 at 7:14 AM

$DVAX from YMB and so true ... "all these mice studies" LMAO .... .

0 · Reply

KWalzz Jun. 25 at 8:44 PM

$DVAX don't think anyone is interested, but here the update on short interest (source: nasdaq) ... no change here.

0 · Reply

KWalzz Jun. 25 at 2:14 PM

$DVAX just another month and we will see how Heplisav sales were developing (or not). the first milestone after the proxy vote for our boys, Scotty and Ryan!

1 · Reply

KWalzz Jun. 25 at 2:00 PM

$DVAX do not invest here until real news is offered by management (LOL). repeat: do not invest here until REAL NEWS is offered by management (LOL again).

0 · Reply

AccuRoger Jun. 25 at 1:57 PM

0 · Reply

KWalzz Jun. 24 at 7:21 PM

$DVAX where are R & S? in there?

0 · Reply

KWalzz Jun. 24 at 3:01 PM

0 · Reply

KWalzz Jun. 24 at 1:46 PM

0 · Reply

HeadlessHorsemen Jun. 23 at 8:15 PM

$DVAX Well, I feel so much better now. DVAX is in its cozy spot at $9+. Thanks GS and Scott Myers! You guys really know how to run a company!!!!

0 · Reply

Buy_dvax100 Jun. 23 at 9:25 AM

$DVAX

4 · Reply

KWalzz Jun. 20 at 9:55 PM

$DVAX today's high volume is due to triple witching day, nothing special here ... like all with regard to Dynavax, nothing special.

0 · Reply

KWalzz Jun. 20 at 9:48 PM

$DVAX

0 · Reply

Barry64 Jun. 20 at 9:19 PM

$DVAX “Of all the sad words of tongue or pen, The saddest are these, ‘It might have been’." From “Maud Muller”, by John Greenleaf Whittier.

0 · Reply

AccuRoger Jun. 20 at 12:33 PM

$DVAX Mice and USA researchers still like the results provided by CpG 1018. This is similar to the work being done by DVAX partner Sinai. The Universal Flu market is huge should this study progress to humans. Conclusions: Overall, CpG 1018 adjuvanted COBRA HA/NA elicited enhanced protective antibodies compared to the unadjuvanted vaccine against several drifted H1N1 and H3N2 influenza viruses in pre-immune mice that were either intramuscularly or intranasally vaccinated with a balanced Th1/Th2 immune response. https://www.mdpi.com/2076-393X/13/7/662

0 · Reply

HeadlessHorsemen Jun. 19 at 5:06 PM

$DVAX DeepTrack did very well in the recent Board fight election since they own 15% of DVAX. They garnered almost 35% of the vote which means they have other institutional support besides the meager 2% owned by private investors. So the pressure is on Scott Myers and his cohorts. The microscope is on them. ISS can not do the same dirty duty they did for Goldman Sachs next election cycle. And GS is now exposed for their duplicity. DeepTrack needs to stay in and fight again

1 · Reply

Estimize Jun. 19 at 2:02 PM

Wall St is expecting 0.10 EPS for $DVAX Q2 [Reporting 07/31 AMC] http://www.estimize.com/intro/dvax?chart=historical&metric_name=eps&utm_co

0 · Reply

KWalzz Jun. 19 at 12:55 PM

$DVAX Deep Track already won over big investors in their lost proxy fight. 59 millon shares pro dvax directors versus 37 millon against. If dynavax management continues to sleep and fail in 2026 DT will win absolutely I am sure. Very interesting times ahead...and I'm sure we will see maximum pressure here soon.

1 · Reply

Buy_dvax100 Jun. 18 at 7:45 PM

$DVAX 2x the avg daily vol

1 · Reply

Buy_dvax100 Jun. 18 at 3:26 PM

$DVAX 👀

0 · Reply

freeze19 Jun. 18 at 2:36 PM

$DVAX Don't we have to go to 15 so that they can sell all their free shares?

2 · Reply

KWalzz Jun. 18 at 1:13 PM

$DVAX 5s really coming? I hope not, but if the shareholder value creation by Scott Myers continues here in same successful way even 4s are possible.

0 · Reply

Market Cap	1.19B
Revenue (ttm)	277.25M
Net Income (ttm)	27.31M
EPS (ttm)	N/A
PE Ratio	69.79
Forward PE	N/A
Profit Margin	9.85%
Debt to Equity Ratio	0.00

Volume	936,100
Avg Vol	2,142,700
Day's Range	N/A - N/A
Shares Out	120.08M
Stochastic %K	20%
Beta	1.06
Analysts	Sell
Price Target	$22.00